BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28991234)

  • 1. DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.
    Jing Y; Nguyen MM; Wang D; Pascal LE; Guo W; Xu Y; Ai J; Deng FM; Masoodi KZ; Yu X; Zhang J; Nelson JB; Xia S; Wang Z
    Oncogene; 2018 Feb; 37(5):638-650. PubMed ID: 28991234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells.
    Fan L; Peng G; Hussain A; Fazli L; Guns E; Gleave M; Qi J
    J Biol Chem; 2015 Aug; 290(34):20865-20879. PubMed ID: 26160177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.
    Xu Y; Song Q; Pascal LE; Zhong M; Zhou Y; Zhou J; Deng FM; Huang J; Wang Z
    Prostate; 2019 May; 79(6):657-666. PubMed ID: 30714180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.
    Qi J; Tripathi M; Mishra R; Sahgal N; Fazli L; Ettinger S; Placzek WJ; Claps G; Chung LW; Bowtell D; Gleave M; Bhowmick N; Ronai ZA
    Cancer Cell; 2013 Mar; 23(3):332-46. PubMed ID: 23518348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy.
    Liao Y; Liu Y; Xia X; Shao Z; Huang C; He J; Jiang L; Tang D; Liu J; Huang H
    Theranostics; 2020; 10(8):3366-3381. PubMed ID: 32206096
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on "the E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity." Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA, Signal Transduction Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.: Cancer Cell 2013;23(6):332-46.
    Olumi AF
    Urol Oncol; 2014 Feb; 32(2):210-1. PubMed ID: 24445292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
    Shen T; Wang W; Zhou W; Coleman I; Cai Q; Dong B; Ittmann MM; Creighton CJ; Bian Y; Meng Y; Rowley DR; Nelson PS; Moore DD; Yang F
    J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G3BP1 inhibits Cul3
    Mukhopadhyay C; Yang C; Xu L; Liu D; Wang Y; Huang D; Deonarine LD; Cyrta J; Davicioni E; Sboner A; Robinson BD; Chinnaiyan AM; Rubin MA; Barbieri CE; Zhou P
    Nat Commun; 2021 Nov; 12(1):6662. PubMed ID: 34795264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo.
    Thomas C; Zoubeidi A; Kuruma H; Fazli L; Lamoureux F; Beraldi E; Monia BP; MacLeod AR; Thüroff JW; Gleave ME
    Mol Cancer Ther; 2011 Feb; 10(2):347-59. PubMed ID: 21216933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splicing Factor Prp8 Interacts With NES(AR) and Regulates Androgen Receptor in Prostate Cancer Cells.
    Wang D; Nguyen MM; Masoodi KZ; Singh P; Jing Y; O'Malley K; Dar JA; Dhir R; Wang Z
    Mol Endocrinol; 2015 Dec; 29(12):1731-42. PubMed ID: 26371515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
    Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
    Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinating enzyme Usp12 is a novel co-activator of the androgen receptor.
    Burska UL; Harle VJ; Coffey K; Darby S; Ramsey H; O'Neill D; Logan IR; Gaughan L; Robson CN
    J Biol Chem; 2013 Nov; 288(45):32641-32650. PubMed ID: 24056413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells.
    Miyajima N; Maruyama S; Bohgaki M; Kano S; Shigemura M; Shinohara N; Nonomura K; Hatakeyama S
    Cancer Res; 2008 May; 68(9):3486-94. PubMed ID: 18451177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ADT-Induced Activation of the E3 Ubiquitin Ligase Siah2 to Delay the Occurrence of Castration-Resistant Prostate Cancer.
    Yan T; Zhou D; Shi Y; Cui D; Jiang J; Han B; Xia S; Wang Z; Liu H; Guo W; Jing Y
    Front Oncol; 2021; 11():637040. PubMed ID: 33937036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
    Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
    Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
    Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
    J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation.
    Gong Y; Wang D; Dar JA; Singh P; Graham L; Liu W; Ai J; Xin Z; Guo Y; Wang Z
    Endocrinology; 2012 Dec; 153(12):5716-25. PubMed ID: 23041672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertad1 promotes prostate cancer progression through binding androgen receptor ligand binding domain.
    Hu B; Hu H; Yin M; Sun Z; Chen X; Li Y; Sun Z; Liu C; Li L; Qiu Y
    Int J Cancer; 2019 Feb; 144(3):558-568. PubMed ID: 30230528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.